One of the most exciting sectors in the stock market is biotechnology. No other sector has the same promise of extraordinary rewards for investors as biotech stocks, to say nothing of the patients who will benefit from the new drugs and treatments that are developed.
Biotechnology companies are working in solutions for some of the worlds most feared and widespread diseases. They are searching for way to make life both better and longer with some degree of success.
Every year new drugs are introduced that treat things like cancer, hepatitis, diabetes, HIV and other diseases. The companies that develop successful drugs have the potential to drive wildly successful biotech stocks.
The flip side of that is that those who disappoint or fail to get their drugs approved can see their stock price collapse. Fortunately we can use Portfolio Grader to help find those biotech stocks that have the very best fundamentals and greatest chance for an investing success story.
Let’s take a look at what Portfolio grader has in mind for biotech stocks to buy now: